NASDAQ Market System Status - Today's
System Status Messages
| Time | Market | Status |
|---|---|---|
| 10:28:15 ET | NASDAQ Options PHLX | Nasdaq Options Exchanges have declared Self-Help on NYSE AMEX Options as of 10:27am ET All Nasdaq Options Systems are operating normally. Please contact the Options Help Desk with any questions (215) 496-1571 OptionsHelpdesk@Nasdaq.com. |
| 08:33:58 ET | NASDAQ | Apex Critical Metals Corp. (APXC) will be released on NASDAQ today for quotation at 10:10 ET and trading at approximately 10:20 ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading prohibited during quote-only period. Per Rule 4120(c)(9), this new issue is eligible for participation in the IPO Cross. |
Regulatory Messages
| Time | Market | Status |
|---|---|---|
| 16:23:59 ET | NASDAQ NTX NASDAQ Options | There are no messages available |
IPO Messages
| Time | Market | Status |
|---|---|---|
| 11:56:14 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc.- LYCA, has officially opened for trading. Time:11:54:50 For additional information please contact Nasdaq Trading Services at (212) 231-5180. |
| 11:50:27 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Lycia Therapeutics, Inc.- LYCA, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:41:32 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:30:21 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:20:30 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:10:32 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:00:19 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:50:54 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:40:51 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:31:32 ET | NASDAQ | IPO Notice Update: The initial public offering of Lycia Therapeutics, Inc. (LYCA) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:21:54 ET | NASDAQ | IPO Notice Update: The initial public offering of APEX CRITICAL ADS - APXC has officially opened for trading. Time: 10:20:03 For additional information please contact Nasdaq Trading Services at (212) 231-5180. |
| 08:00:12 ET | NASDAQ | IPO Notice: The initial public offering of Lycia Therapeutics, Inc. (LYCA) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs. |
Self-Help Messages
| Time | Market | Status |
|---|---|---|
| 16:23:59 ET | NASDAQ NTX PSX NASDAQ Options | There are no messages available |

RSS Feeds
Product Login